Multiplikator Forward P/S: RxSight (RXST)
The forward P/S ratio demonstrates a market overvaluation of RxSight, Inc. (RXST), whose dominance in the adjustable IOL segment is protected by patents. Meanwhile, the 1.80 value serves as the baseline indicator for price action. The stability of the R&D staff and active recruitment of sales agents are complemented by precision optics delivery logistics, ensuring the preservation of lens properties during transport.
Ringkesan rincian data analitis RxSight Ophthalmic (RXST)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal RxSight, Inc.|RXST - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal RxSight, Inc.|RXST - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku RxSight Ophthalmic|RXST - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan RxSight|Rasio cepet rxsight.com
- rincian asil keuangan lan kelipatan valuasi:
RXST - Penghasilan resik perusahaan|Bathi sing dikarepake RxSight, Inc.|RXST - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi RxSight Corp|RXST - Pangali PEG|Pangali EV/EBITDA RxSight Ophthalmic|RXST - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan RxSight|RXST - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan rxsight.com|RXST - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep RxSight, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:RXST (RxSight)
The scale of the adoption of RxSight, Inc. (RXST) innovative light technologies in ophthalmic surgery correlates directly with the price action of the forward P/S chart. This metric reflects the market value of every dollar of expected revenue, allowing investors to assess the current balance of supply and demand through the ratio of market capitalization to projected sales, where an upward trend signals growing confidence in the future pace of business expansion.
Karo sapa RxSight, Inc. saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|vivani.com (VANI) - Rasio rega marang prakiraan pendapatan|Xtant Medical - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan NMTC|Kapitalisasi marang prakiraan pendapatan MODD (Modular Med)|Rasio rega marang prakiraan pendapatan Myomo, Inc (MYO)|Rasio kapitalisasi marang dodolan sing dikarepake Envoy Medical Inc|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Rasio kapitalisasi marang dodolan sing dikarepake envveno.com (NVNO)|SINTX Technologies - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Tenon Medical Inc. (TNON)|LFWD: Multiplikator Forward P/S|Autonomix Medical - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan IVF|BBLG (bonebiologics.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan AXNX (Axonics)|BIOL (BIOLASE Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (Dynatronics)|Rasio kapitalisasi marang dodolan sing dikarepake Paragon 28 Inc. (FNA)|INVO - Rasio rega marang prakiraan pendapatan
